[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cell Line Development Serum Market Growth 2022-2028

January 2022 | 103 pages | ID: G783E516EFD1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Cell Line Development Serum will have significant change from previous year. According to our (LP Information) latest study, the global Cell Line Development Serum market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cell Line Development Serum market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cell Line Development Serum market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cell Line Development Serum market, reaching US$ million by the year 2028. As for the Europe Cell Line Development Serum landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cell Line Development Serum players cover American Type Culture Collection (ATCC) (US), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (US), and GE Healthcare (U.K.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Development Serum market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Fetal Bovine Serum
  • Adult Bovine Serum
  • Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Tissue Engineering & Regenerative Medicines
  • Toxicity Testing
  • Research
  • Drug Discovery
  • Bioproduction
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • American Type Culture Collection (ATCC) (US)
  • Lonza Group AG (Switzerland)
  • Thermo Fisher Scientific, Inc. (US)
  • GE Healthcare (U.K.)
  • Sigma-Aldrich Corporation (US)
  • Selexis SA (Switzerland)
  • European Collection of Cell Cultures (ECACC) (U.K.)
  • Corning, Inc. (US)
  • WuXi AppTec, Inc. (China)
  • Sartorious AG (Germany)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cell Line Development Serum Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Cell Line Development Serum by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Cell Line Development Serum by Country/Region, 2017, 2022 & 2028
2.2 Cell Line Development Serum Segment by Type
  2.2.1 Fetal Bovine Serum
  2.2.2 Adult Bovine Serum
  2.2.3 Others
2.3 Cell Line Development Serum Sales by Type
  2.3.1 Global Cell Line Development Serum Sales Market Share by Type (2017-2022)
  2.3.2 Global Cell Line Development Serum Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Cell Line Development Serum Sale Price by Type (2017-2022)
2.4 Cell Line Development Serum Segment by Application
  2.4.1 Tissue Engineering & Regenerative Medicines
  2.4.2 Toxicity Testing
  2.4.3 Research
  2.4.4 Drug Discovery
  2.4.5 Bioproduction
2.5 Cell Line Development Serum Sales by Application
  2.5.1 Global Cell Line Development Serum Sale Market Share by Application (2017-2022)
  2.5.2 Global Cell Line Development Serum Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Cell Line Development Serum Sale Price by Application (2017-2022)

3 GLOBAL CELL LINE DEVELOPMENT SERUM BY COMPANY

3.1 Global Cell Line Development Serum Breakdown Data by Company
  3.1.1 Global Cell Line Development Serum Annual Sales by Company (2020-2022)
  3.1.2 Global Cell Line Development Serum Sales Market Share by Company (2020-2022)
3.2 Global Cell Line Development Serum Annual Revenue by Company (2020-2022)
  3.2.1 Global Cell Line Development Serum Revenue by Company (2020-2022)
  3.2.2 Global Cell Line Development Serum Revenue Market Share by Company (2020-2022)
3.3 Global Cell Line Development Serum Sale Price by Company
3.4 Key Manufacturers Cell Line Development Serum Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Cell Line Development Serum Product Location Distribution
  3.4.2 Players Cell Line Development Serum Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR CELL LINE DEVELOPMENT SERUM BY GEOGRAPHIC REGION

4.1 World Historic Cell Line Development Serum Market Size by Geographic Region (2017-2022)
  4.1.1 Global Cell Line Development Serum Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Cell Line Development Serum Annual Revenue by Geographic Region
4.2 World Historic Cell Line Development Serum Market Size by Country/Region (2017-2022)
  4.2.1 Global Cell Line Development Serum Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Cell Line Development Serum Annual Revenue by Country/Region
4.3 Americas Cell Line Development Serum Sales Growth
4.4 APAC Cell Line Development Serum Sales Growth
4.5 Europe Cell Line Development Serum Sales Growth
4.6 Middle East & Africa Cell Line Development Serum Sales Growth

5 AMERICAS

5.1 Americas Cell Line Development Serum Sales by Country
  5.1.1 Americas Cell Line Development Serum Sales by Country (2017-2022)
  5.1.2 Americas Cell Line Development Serum Revenue by Country (2017-2022)
5.2 Americas Cell Line Development Serum Sales by Type
5.3 Americas Cell Line Development Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cell Line Development Serum Sales by Region
  6.1.1 APAC Cell Line Development Serum Sales by Region (2017-2022)
  6.1.2 APAC Cell Line Development Serum Revenue by Region (2017-2022)
6.2 APAC Cell Line Development Serum Sales by Type
6.3 APAC Cell Line Development Serum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Cell Line Development Serum by Country
  7.1.1 Europe Cell Line Development Serum Sales by Country (2017-2022)
  7.1.2 Europe Cell Line Development Serum Revenue by Country (2017-2022)
7.2 Europe Cell Line Development Serum Sales by Type
7.3 Europe Cell Line Development Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cell Line Development Serum by Country
  8.1.1 Middle East & Africa Cell Line Development Serum Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Cell Line Development Serum Revenue by Country (2017-2022)
8.2 Middle East & Africa Cell Line Development Serum Sales by Type
8.3 Middle East & Africa Cell Line Development Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell Line Development Serum
10.3 Manufacturing Process Analysis of Cell Line Development Serum
10.4 Industry Chain Structure of Cell Line Development Serum

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Cell Line Development Serum Distributors
11.3 Cell Line Development Serum Customer

12 WORLD FORECAST REVIEW FOR CELL LINE DEVELOPMENT SERUM BY GEOGRAPHIC REGION

12.1 Global Cell Line Development Serum Market Size Forecast by Region
  12.1.1 Global Cell Line Development Serum Forecast by Region (2023-2028)
  12.1.2 Global Cell Line Development Serum Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell Line Development Serum Forecast by Type
12.7 Global Cell Line Development Serum Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 American Type Culture Collection (ATCC) (US)
  13.1.1 American Type Culture Collection (ATCC) (US) Company Information
  13.1.2 American Type Culture Collection (ATCC) (US) Cell Line Development Serum Product Offered
  13.1.3 American Type Culture Collection (ATCC) (US) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 American Type Culture Collection (ATCC) (US) Main Business Overview
  13.1.5 American Type Culture Collection (ATCC) (US) Latest Developments
13.2 Lonza Group AG (Switzerland)
  13.2.1 Lonza Group AG (Switzerland) Company Information
  13.2.2 Lonza Group AG (Switzerland) Cell Line Development Serum Product Offered
  13.2.3 Lonza Group AG (Switzerland) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Lonza Group AG (Switzerland) Main Business Overview
  13.2.5 Lonza Group AG (Switzerland) Latest Developments
13.3 Thermo Fisher Scientific, Inc. (US)
  13.3.1 Thermo Fisher Scientific, Inc. (US) Company Information
  13.3.2 Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Product Offered
  13.3.3 Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Thermo Fisher Scientific, Inc. (US) Main Business Overview
  13.3.5 Thermo Fisher Scientific, Inc. (US) Latest Developments
13.4 GE Healthcare (U.K.)
  13.4.1 GE Healthcare (U.K.) Company Information
  13.4.2 GE Healthcare (U.K.) Cell Line Development Serum Product Offered
  13.4.3 GE Healthcare (U.K.) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 GE Healthcare (U.K.) Main Business Overview
  13.4.5 GE Healthcare (U.K.) Latest Developments
13.5 Sigma-Aldrich Corporation (US)
  13.5.1 Sigma-Aldrich Corporation (US) Company Information
  13.5.2 Sigma-Aldrich Corporation (US) Cell Line Development Serum Product Offered
  13.5.3 Sigma-Aldrich Corporation (US) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Sigma-Aldrich Corporation (US) Main Business Overview
  13.5.5 Sigma-Aldrich Corporation (US) Latest Developments
13.6 Selexis SA (Switzerland)
  13.6.1 Selexis SA (Switzerland) Company Information
  13.6.2 Selexis SA (Switzerland) Cell Line Development Serum Product Offered
  13.6.3 Selexis SA (Switzerland) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Selexis SA (Switzerland) Main Business Overview
  13.6.5 Selexis SA (Switzerland) Latest Developments
13.7 European Collection of Cell Cultures (ECACC) (U.K.)
  13.7.1 European Collection of Cell Cultures (ECACC) (U.K.) Company Information
  13.7.2 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Product Offered
  13.7.3 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 European Collection of Cell Cultures (ECACC) (U.K.) Main Business Overview
  13.7.5 European Collection of Cell Cultures (ECACC) (U.K.) Latest Developments
13.8 Corning, Inc. (US)
  13.8.1 Corning, Inc. (US) Company Information
  13.8.2 Corning, Inc. (US) Cell Line Development Serum Product Offered
  13.8.3 Corning, Inc. (US) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Corning, Inc. (US) Main Business Overview
  13.8.5 Corning, Inc. (US) Latest Developments
13.9 WuXi AppTec, Inc. (China)
  13.9.1 WuXi AppTec, Inc. (China) Company Information
  13.9.2 WuXi AppTec, Inc. (China) Cell Line Development Serum Product Offered
  13.9.3 WuXi AppTec, Inc. (China) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 WuXi AppTec, Inc. (China) Main Business Overview
  13.9.5 WuXi AppTec, Inc. (China) Latest Developments
13.10 Sartorious AG (Germany)
  13.10.1 Sartorious AG (Germany) Company Information
  13.10.2 Sartorious AG (Germany) Cell Line Development Serum Product Offered
  13.10.3 Sartorious AG (Germany) Cell Line Development Serum Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Sartorious AG (Germany) Main Business Overview
  13.10.5 Sartorious AG (Germany) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Cell Line Development Serum Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cell Line Development Serum Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Fetal Bovine Serum
Table 4. Major Players of Adult Bovine Serum
Table 5. Major Players of Others
Table 6. Global Cell Line Development Serum Sales by Type (2017-2022) & (K Pcs)
Table 7. Global Cell Line Development Serum Sales Market Share by Type (2017-2022)
Table 8. Global Cell Line Development Serum Revenue by Type (2017-2022) & ($ million)
Table 9. Global Cell Line Development Serum Revenue Market Share by Type (2017-2022)
Table 10. Global Cell Line Development Serum Sale Price by Type (2017-2022) & (USD/Pcs)
Table 11. Global Cell Line Development Serum Sales by Application (2017-2022) & (K Pcs)
Table 12. Global Cell Line Development Serum Sales Market Share by Application (2017-2022)
Table 13. Global Cell Line Development Serum Revenue by Application (2017-2022)
Table 14. Global Cell Line Development Serum Revenue Market Share by Application (2017-2022)
Table 15. Global Cell Line Development Serum Sale Price by Application (2017-2022) & (USD/Pcs)
Table 16. Global Cell Line Development Serum Sales by Company (2020-2022) & (K Pcs)
Table 17. Global Cell Line Development Serum Sales Market Share by Company (2020-2022)
Table 18. Global Cell Line Development Serum Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Cell Line Development Serum Revenue Market Share by Company (2020-2022)
Table 20. Global Cell Line Development Serum Sale Price by Company (2020-2022) & (USD/Pcs)
Table 21. Key Manufacturers Cell Line Development Serum Producing Area Distribution and Sales Area
Table 22. Players Cell Line Development Serum Products Offered
Table 23. Cell Line Development Serum Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cell Line Development Serum Sales by Geographic Region (2017-2022) & (K Pcs)
Table 27. Global Cell Line Development Serum Sales Market Share Geographic Region (2017-2022)
Table 28. Global Cell Line Development Serum Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Cell Line Development Serum Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Cell Line Development Serum Sales by Country/Region (2017-2022) & (K Pcs)
Table 31. Global Cell Line Development Serum Sales Market Share by Country/Region (2017-2022)
Table 32. Global Cell Line Development Serum Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Cell Line Development Serum Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Cell Line Development Serum Sales by Country (2017-2022) & (K Pcs)
Table 35. Americas Cell Line Development Serum Sales Market Share by Country (2017-2022)
Table 36. Americas Cell Line Development Serum Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Cell Line Development Serum Revenue Market Share by Country (2017-2022)
Table 38. Americas Cell Line Development Serum Sales by Type (2017-2022) & (K Pcs)
Table 39. Americas Cell Line Development Serum Sales Market Share by Type (2017-2022)
Table 40. Americas Cell Line Development Serum Sales by Application (2017-2022) & (K Pcs)
Table 41. Americas Cell Line Development Serum Sales Market Share by Application (2017-2022)
Table 42. APAC Cell Line Development Serum Sales by Region (2017-2022) & (K Pcs)
Table 43. APAC Cell Line Development Serum Sales Market Share by Region (2017-2022)
Table 44. APAC Cell Line Development Serum Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Cell Line Development Serum Revenue Market Share by Region (2017-2022)
Table 46. APAC Cell Line Development Serum Sales by Type (2017-2022) & (K Pcs)
Table 47. APAC Cell Line Development Serum Sales Market Share by Type (2017-2022)
Table 48. APAC Cell Line Development Serum Sales by Application (2017-2022) & (K Pcs)
Table 49. APAC Cell Line Development Serum Sales Market Share by Application (2017-2022)
Table 50. Europe Cell Line Development Serum Sales by Country (2017-2022) & (K Pcs)
Table 51. Europe Cell Line Development Serum Sales Market Share by Country (2017-2022)
Table 52. Europe Cell Line Development Serum Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Cell Line Development Serum Revenue Market Share by Country (2017-2022)
Table 54. Europe Cell Line Development Serum Sales by Type (2017-2022) & (K Pcs)
Table 55. Europe Cell Line Development Serum Sales Market Share by Type (2017-2022)
Table 56. Europe Cell Line Development Serum Sales by Application (2017-2022) & (K Pcs)
Table 57. Europe Cell Line Development Serum Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Cell Line Development Serum Sales by Country (2017-2022) & (K Pcs)
Table 59. Middle East & Africa Cell Line Development Serum Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Cell Line Development Serum Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Cell Line Development Serum Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cell Line Development Serum Sales by Type (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Cell Line Development Serum Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Cell Line Development Serum Sales by Application (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Cell Line Development Serum Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Cell Line Development Serum
Table 67. Key Market Challenges & Risks of Cell Line Development Serum
Table 68. Key Industry Trends of Cell Line Development Serum
Table 69. Cell Line Development Serum Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Cell Line Development Serum Distributors List
Table 72. Cell Line Development Serum Customer List
Table 73. Global Cell Line Development Serum Sales Forecast by Region (2023-2028) & (K Pcs)
Table 74. Global Cell Line Development Serum Sales Market Forecast by Region
Table 75. Global Cell Line Development Serum Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Cell Line Development Serum Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Cell Line Development Serum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 78. Americas Cell Line Development Serum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Cell Line Development Serum Sales Forecast by Region (2023-2028) & (K Pcs)
Table 80. APAC Cell Line Development Serum Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Cell Line Development Serum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Europe Cell Line Development Serum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Cell Line Development Serum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Cell Line Development Serum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Cell Line Development Serum Sales Forecast by Type (2023-2028) & (K Pcs)
Table 86. Global Cell Line Development Serum Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Cell Line Development Serum Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Cell Line Development Serum Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Cell Line Development Serum Sales Forecast by Application (2023-2028) & (K Pcs)
Table 90. Global Cell Line Development Serum Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Cell Line Development Serum Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Cell Line Development Serum Revenue Market Share Forecast by Application (2023-2028)
Table 93. American Type Culture Collection (ATCC) (US) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 94. American Type Culture Collection (ATCC) (US) Cell Line Development Serum Product Offered
Table 95. American Type Culture Collection (ATCC) (US) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 96. American Type Culture Collection (ATCC) (US) Main Business
Table 97. American Type Culture Collection (ATCC) (US) Latest Developments
Table 98. Lonza Group AG (Switzerland) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 99. Lonza Group AG (Switzerland) Cell Line Development Serum Product Offered
Table 100. Lonza Group AG (Switzerland) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Lonza Group AG (Switzerland) Main Business
Table 102. Lonza Group AG (Switzerland) Latest Developments
Table 103. Thermo Fisher Scientific, Inc. (US) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 104. Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Product Offered
Table 105. Thermo Fisher Scientific, Inc. (US) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Thermo Fisher Scientific, Inc. (US) Main Business
Table 107. Thermo Fisher Scientific, Inc. (US) Latest Developments
Table 108. GE Healthcare (U.K.) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 109. GE Healthcare (U.K.) Cell Line Development Serum Product Offered
Table 110. GE Healthcare (U.K.) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. GE Healthcare (U.K.) Main Business
Table 112. GE Healthcare (U.K.) Latest Developments
Table 113. Sigma-Aldrich Corporation (US) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 114. Sigma-Aldrich Corporation (US) Cell Line Development Serum Product Offered
Table 115. Sigma-Aldrich Corporation (US) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. Sigma-Aldrich Corporation (US) Main Business
Table 117. Sigma-Aldrich Corporation (US) Latest Developments
Table 118. Selexis SA (Switzerland) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 119. Selexis SA (Switzerland) Cell Line Development Serum Product Offered
Table 120. Selexis SA (Switzerland) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Selexis SA (Switzerland) Main Business
Table 122. Selexis SA (Switzerland) Latest Developments
Table 123. European Collection of Cell Cultures (ECACC) (U.K.) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 124. European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Product Offered
Table 125. European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. European Collection of Cell Cultures (ECACC) (U.K.) Main Business
Table 127. European Collection of Cell Cultures (ECACC) (U.K.) Latest Developments
Table 128. Corning, Inc. (US) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 129. Corning, Inc. (US) Cell Line Development Serum Product Offered
Table 130. Corning, Inc. (US) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. Corning, Inc. (US) Main Business
Table 132. Corning, Inc. (US) Latest Developments
Table 133. WuXi AppTec, Inc. (China) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 134. WuXi AppTec, Inc. (China) Cell Line Development Serum Product Offered
Table 135. WuXi AppTec, Inc. (China) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 136. WuXi AppTec, Inc. (China) Main Business
Table 137. WuXi AppTec, Inc. (China) Latest Developments
Table 138. Sartorious AG (Germany) Basic Information, Cell Line Development Serum Manufacturing Base, Sales Area and Its Competitors
Table 139. Sartorious AG (Germany) Cell Line Development Serum Product Offered
Table 140. Sartorious AG (Germany) Cell Line Development Serum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 141. Sartorious AG (Germany) Main Business
Table 142. Sartorious AG (Germany) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Cell Line Development Serum
Figure 2. Cell Line Development Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cell Line Development Serum Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Cell Line Development Serum Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cell Line Development Serum Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Fetal Bovine Serum
Figure 10. Product Picture of Adult Bovine Serum
Figure 11. Product Picture of Others
Figure 12. Global Cell Line Development Serum Sales Market Share by Type in 2021
Figure 13. Global Cell Line Development Serum Revenue Market Share by Type (2017-2022)
Figure 14. Cell Line Development Serum Consumed in Tissue Engineering & Regenerative Medicines
Figure 15. Global Cell Line Development Serum Market: Tissue Engineering & Regenerative Medicines (2017-2022) & (K Pcs)
Figure 16. Cell Line Development Serum Consumed in Toxicity Testing
Figure 17. Global Cell Line Development Serum Market: Toxicity Testing (2017-2022) & (K Pcs)
Figure 18. Cell Line Development Serum Consumed in Research
Figure 19. Global Cell Line Development Serum Market: Research (2017-2022) & (K Pcs)
Figure 20. Cell Line Development Serum Consumed in Drug Discovery
Figure 21. Global Cell Line Development Serum Market: Drug Discovery (2017-2022) & (K Pcs)
Figure 22. Cell Line Development Serum Consumed in Bioproduction
Figure 23. Global Cell Line Development Serum Market: Bioproduction (2017-2022) & (K Pcs)
Figure 24. Global Cell Line Development Serum Sales Market Share by Application (2017-2022)
Figure 25. Global Cell Line Development Serum Revenue Market Share by Application in 2021
Figure 26. Cell Line Development Serum Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Cell Line Development Serum Revenue Market Share by Company in 2021
Figure 28. Global Cell Line Development Serum Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Cell Line Development Serum Revenue Market Share by Geographic Region in 2021
Figure 30. Global Cell Line Development Serum Sales Market Share by Region (2017-2022)
Figure 31. Global Cell Line Development Serum Revenue Market Share by Country/Region in 2021
Figure 32. Americas Cell Line Development Serum Sales 2017-2022 (K Pcs)
Figure 33. Americas Cell Line Development Serum Revenue 2017-2022 ($ Millions)
Figure 34. APAC Cell Line Development Serum Sales 2017-2022 (K Pcs)
Figure 35. APAC Cell Line Development Serum Revenue 2017-2022 ($ Millions)
Figure 36. Europe Cell Line Development Serum Sales 2017-2022 (K Pcs)
Figure 37. Europe Cell Line Development Serum Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Cell Line Development Serum Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Cell Line Development Serum Revenue 2017-2022 ($ Millions)
Figure 40. Americas Cell Line Development Serum Sales Market Share by Country in 2021
Figure 41. Americas Cell Line Development Serum Revenue Market Share by Country in 2021
Figure 42. United States Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Cell Line Development Serum Sales Market Share by Region in 2021
Figure 47. APAC Cell Line Development Serum Revenue Market Share by Regions in 2021
Figure 48. China Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Cell Line Development Serum Sales Market Share by Country in 2021
Figure 55. Europe Cell Line Development Serum Revenue Market Share by Country in 2021
Figure 56. Germany Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Cell Line Development Serum Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Cell Line Development Serum Revenue Market Share by Country in 2021
Figure 63. Egypt Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Cell Line Development Serum Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Cell Line Development Serum in 2021
Figure 69. Manufacturing Process Analysis of Cell Line Development Serum
Figure 70. Industry Chain Structure of Cell Line Development Serum
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


More Publications